These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Prevention of postoperative adhesions by intraperitoneal medication--an experimental study. Qiu HD; Shi HA J Tongji Med Univ; 1987; 7(3):173-5. PubMed ID: 3448244 [No Abstract] [Full Text] [Related]
44. Interceed (TC7) as an adjuvant for adhesion reduction: animal studies. Diamond MP; Cunningham T; Linsky CB; Kamp L; McConnell RF; Gracy RW Prog Clin Biol Res; 1990; 358():131-43. PubMed ID: 2217489 [No Abstract] [Full Text] [Related]
45. The preventive effect of Met-RANTES on postoperative intraperitoneal adhesion formation in the rat model. Akyildiz H; Akcan A; Sozuer E; Kucuk C; Yilmaz N; Deniz K Surgery; 2008 Sep; 144(3):404-9. PubMed ID: 18707039 [TBL] [Abstract][Full Text] [Related]
46. Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5-fluorouracil: experimental studies. Pestieau SR; Marchettini P; Stuart OA; Chang D; Sugarbaker PH Int Surg; 2002; 87(3):195-200. PubMed ID: 12403098 [TBL] [Abstract][Full Text] [Related]
48. Reduction of intraperitoneal adhesion formation by use of non-abrasive gauze. van den Tol MP; van Stijn I; Bonthuis F; Marquet RL; Jeekel J Br J Surg; 1997 Oct; 84(10):1410-5. PubMed ID: 9361601 [TBL] [Abstract][Full Text] [Related]
49. Prevention of Peritoneal Adhesions by Non-Thermal Dielectric Barrier Discharge Plasma Treatment on Mouse Model: A Proof of Concept Study. Gökçelli U; Ercan UK; İlhan E; Argon A; Çukur E; Üreyen O J Invest Surg; 2020 Aug; 33(7):605-614. PubMed ID: 30644787 [No Abstract] [Full Text] [Related]
50. Effects of pyrolytic carbon on postoperative adhesion formation in rats. Demirbag S; Atabek C; Guven A; Oztas E; Surer I; Ozturk H; Yesildaglar N Arch Gynecol Obstet; 2009 Jan; 279(1):11-5. PubMed ID: 18418619 [TBL] [Abstract][Full Text] [Related]
52. Development of peritoneal adhesions in macrophage depleted mice. Burnett SH; Beus BJ; Avdiushko R; Qualls J; Kaplan AM; Cohen DA J Surg Res; 2006 Apr; 131(2):296-301. PubMed ID: 16289593 [TBL] [Abstract][Full Text] [Related]
53. TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation. Chegini N Semin Reprod Med; 2008 Jul; 26(4):298-312. PubMed ID: 18756407 [TBL] [Abstract][Full Text] [Related]
54. The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice. Boudreau C; LeVatte T; Jones C; Gareau A; Legere S; Bezuhly M J Surg Res; 2020 Dec; 256():231-242. PubMed ID: 32711180 [TBL] [Abstract][Full Text] [Related]
55. [Prevention of adhesions by intraperitoneal administration of substances in abdominal interventions]. Henne-Bruns D; Höltig A; Tesch C; Kremer B Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1027-30. PubMed ID: 1983479 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of Interceed in adhesion prevention in gynecologic surgery: a review of 13 clinical studies. Larsson B J Reprod Med; 1996 Jan; 41(1):27-34. PubMed ID: 8855073 [TBL] [Abstract][Full Text] [Related]
57. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis. Tarhan OR; Barut I; Sezik M J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298 [TBL] [Abstract][Full Text] [Related]
58. Peritoneal adhesions: facing the enemy. Ergul E; Korukluoglu B Int J Surg; 2008 Jun; 6(3):253-60. PubMed ID: 17617231 [TBL] [Abstract][Full Text] [Related]
59. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model. Yeo Y; Bellas E; Highley CB; Langer R; Kohane DS Biomaterials; 2007 Sep; 28(25):3704-13. PubMed ID: 17512979 [TBL] [Abstract][Full Text] [Related]